Drug industry veteran Tony Coles takes top spot at Pfizer spinout Cerevel

While his previous venture prepares to start an early stage test of its Parkinson’s disease drug, pharmaceutical industry mainstay Tony Coles has jumped to a startup several steps ahead with its own treatment for the movement disorder.